Prevention and Treatment of Venous Thromboembolism Associated with Corona Virus Disease(COVID-19)
Corona virus disease(COVID-19)can induce thrombotic complications through a variety of mechanisms,among which venous thromboembolism(VTE)is one of the important causes of death or poor prognosis in hospitalized patients with COVID-19.Venous thromboprophylaxis in COVID-19 patients should be used based on the risks of VTE and bleeding.Patients with COVID-19 may have coagulation disorders,which may be exacerbated by organ microthrombi.Anticoagulants may increase the risk of bleeding.In addition,inadequate anticoagulation may lead to increased mortality in critically ill COVID-19 patients.Therefore,early initiation of risk assessment and selection of appropriate preventive and treatment measures are essential to improve patient outcomes.
corona virus disease 19venous thromboembolismthrombosis prophylaxisprevention and treatmentcomplications
万方数据
维普
